New Jersey-based packaging, device and component molder Comar LLC is building a custom facility in Rancho Cucamonga, Calif.
The 230,000-square-foot facility will replace existing Comar plants in Rancho Cucamonga and Garden Grove, Calif.
The new plant will house injection and injection stretch blow molding and injection molding cells. Some 26,000 square feet of space will have ISO Class 8 injection molding and assembly clean rooms.
Comar has secured the new facility and submitted drawings and permit applications. Its goal is to start construction in the spring of 2020 and complete move in and production startup by the end of the year.
"This new facility will provide best-in-class medical device production areas and significant additional capacity to grow with our customers across product lines and market segments," Comar CEO Mike Ruggieri said in a news release.
The new facility will be ISO 13485 certified and will feature a mold prototyping lab, dedicated mold sampling and development equipment. The capabilities will enable Comar to design and prototype new products, and bring them to full production.
Pete Scharber, vice president of direct sales, said combining Comar's West Coast team onto a single campus will create new opportunities to collaborate with medical customers.
Voorhees, N.J.-based Comar was founded in 1949, and it is principally owned by Morgan Stanley Capital Partners. Comar ranked No. 22 on Plastics News' North American blow molders list with $125 million in sales in 2018. The company has eight manufacturing and distribution locations.
In January, Comar announced the purchase of Woodville, Wis.-based medical injection molding specialist iMark Molding Inc.